Angiotensin II receptor blockers in patients with systemic right ventricular dysfunction
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Valsartan (Primary)
- Indications Right ventricular dysfunction
- Focus Therapeutic Use
- Sponsors Novartis
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 02 Feb 2011 Last checked against ISRCTN: Current Controlled Trials.
- 01 Nov 2010 Rationale and trial design were presented in an article in the American heart journal.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History